Your browser doesn't support javascript.
loading
Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer.
Cabezas-Camarero, Santiago; Merino-Menéndez, Salomé; Cabrera-Martín, María Nieves; Sotelo, Miguel J; Plaza-Hernández, José Carlos; Falahat, Farzin; Iglesias-Moreno, María Cruz; Pérez-Segura, Pedro.
Afiliação
  • Cabezas-Camarero S; Head and Neck Cancer, Neuro-Oncology and Genetic Counseling Unit, Medical Oncology Department, Instituto de Investigación Sanitaria San Carlos, Madrid 28040, Spain.
  • Merino-Menéndez S; Radiology Department, Clinico San Carlos University Hospital, Madrid 28040, Spain.
  • Cabrera-Martín MN; Nuclear Medicine Department, Clinico San Carlos University Hospital, Madrid 28040, Spain.
  • Sotelo MJ; Medical Oncology Department, Aliada Cancer Center, San Isidro 15036, Peru.
  • Plaza-Hernández JC; Medical Oncology Department, San Felipe Hospital, Jesús María 15072, Peru.
  • Falahat F; Medical Oncology Department, María Auxiliadora Hospital, San Juan de Miraflores 15801, Peru.
  • Iglesias-Moreno MC; Pathology Department, Clinico San Carlos University Hospital, Madrid 28040, Spain.
  • Pérez-Segura P; Department of Craniomaxilofacial Surgery, Clinico San Carlos University Hospital, Madrid 28040, Spain.
Oncol Lett ; 25(1): 37, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36589672

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article